Literature DB >> 21606009

Risk factors and clinical characteristics of Stenotrophomonas maltophilia infections in neonates.

Mehmet Mutlu1, Gürdal Yılmaz, Yakup Aslan, Gülçin Bayramoğlu.   

Abstract

BACKGROUND: The aim of this study was to review the risk factors and clinical, bacteriological, and epidemiological characteristics of Stenotrophomonas maltophilia infections in our neonatal intensive care unit.
METHODS: A retrospective matched case-control study was performed by comparing 23 cases of S maltophilia with 45 controls to identify the potential risk factors. To identify the case patients, the admission and medical records of patients in the neonatal intensive care unit and records from the Microbiology Department were reviewed between 2003 and 2008.
RESULTS: Sepsis in two neonates (9%), conjunctivitis in two neonates (9%), and ventilator-associated pneumonia in 19 (82%) neonates were determined. Invasive-procedures, exposure to aminoglycoside and carbapenem, total parenteral nutrition, histamine 2 blockers, exposure to steroids, cholestasis, and duration of hospitalization were significantly associated with S maltophilia infections (p<0.05). On multivariate analysis, invasive procedures (odds ratio, 18.81) and duration of hospitalization (odds ratio, 1.06) were determined to be the risk factors for S maltophilia infection. The most active antimicrobial agent was trimethoprim/sulfamethoxazole (87%) for S maltophilia infection, and the mortality rate was 17%.
CONCLUSIONS: Neonatologists should avoid from unnecessary invasive procedures and broad-spectrum antibiotics to reduce S maltophilia infections. Invasive procedures should be finished in the shortest time possible. Agent/factor-specific antibacterial treatment should be administered. Patients being discharged as early as possible will also reduce infection frequency. Stenotrophomonas maltophilia should be considered in patients with high Stenotrophomonas infection risk factors.
Copyright © 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21606009     DOI: 10.1016/j.jmii.2011.04.014

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  10 in total

1.  Trimethoprim-Sulfamethoxazole for Treatment of Stenotrophomonas maltophilia Pneumonia in a Neonate.

Authors:  Karen Leask Ryan; Deonne Dersch-Mills; Deborah Clark
Journal:  Can J Hosp Pharm       Date:  2013-11

2.  Levofloxacin Use in the Neonate: A Case Series.

Authors:  Brandi D Newby; Kathryn E Timberlake; Lyndsay M Lepp; Tamara Mihic; Deonne A Dersch-Mills
Journal:  J Pediatr Pharmacol Ther       Date:  2017 Jul-Aug

3.  Stenotrophomonas maltophilia infection among young children in a cardiac intensive care unit: a single institution experience.

Authors:  Ciji Arthur; Xinyu Tang; Jose R Romero; Jeffrey G Gossett; Nada Harik; Parthak Prodhan
Journal:  Pediatr Cardiol       Date:  2014-10-08       Impact factor: 1.655

4.  High Direct Bilirubin Associated With Levoffoxacin Use in a Neonate.

Authors:  Amy P Holmes; Charles E Hartis; Laurie J Rollins
Journal:  J Pediatr Pharmacol Ther       Date:  2020 Jan-Feb

Review 5.  Emergent Pneumonia in Children.

Authors:  Cecilia Perret; Nicole Le Corre; Jose A Castro-Rodriguez
Journal:  Front Pediatr       Date:  2021-06-17       Impact factor: 3.418

6.  Metagenomic Analysis Identified Stenotrophomonas maltophilia Pneumonia in an Infant Suffering From Unexplained Very Severe Pneumonia.

Authors:  Yan Lin; Bao-Xi Wang; Ni-Ni Zhang; Lei Zhang; Zhi-Bo Gao; Jiao Tian; Xun Jiang
Journal:  Front Pediatr       Date:  2019-09-19       Impact factor: 3.418

7.  Gastric Adenocarcinomas and Signet-Ring Cell Carcinoma: Unraveling Gastric Cancer Complexity through Microbiome Analysis-Deepening Heterogeneity for a Personalized Therapy.

Authors:  Gloria Ravegnini; Bruno Fosso; Viola Di Saverio; Giulia Sammarini; Federica Zanotti; Giulio Rossi; Monica Ricci; Federica D'Amico; Giorgia Valori; Antonella Ioli; Silvia Turroni; Patrizia Brigidi; Patrizia Hrelia; Sabrina Angelini
Journal:  Int J Mol Sci       Date:  2020-12-20       Impact factor: 5.923

8.  Advances in the Microbiology of Stenotrophomonas maltophilia.

Authors:  Joanna S Brooke
Journal:  Clin Microbiol Rev       Date:  2021-05-26       Impact factor: 50.129

9.  Phylogenetic analysis of Stenotrophomonas spp. isolates contributes to the identification of nosocomial and community-acquired infections.

Authors:  Vinicius Godoy Cerezer; Silvia Yumi Bando; Jacyr Pasternak; Marcia Regina Franzolin; Carlos Alberto Moreira-Filho
Journal:  Biomed Res Int       Date:  2014-04-10       Impact factor: 3.411

10.  Emergence of Stenotrophomonas maltophilia nosocomial isolates in a Saudi children's hospital. Risk factors and clinical characteristics.

Authors:  Jobran M Alqahtani
Journal:  Saudi Med J       Date:  2017-05       Impact factor: 1.484

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.